tiprankstipranks
Amgen (MX:AMGN)
:AMGN
Mexico Market
AMGN
Amgen
RESEARCH TOOLSreports

Amgen (AMGN) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

AMGN Analyst Ratings

Moderate Buy
24Ratings
Moderate Buy
9 Buy
13 Hold
2 Sell
Based on 24 analysts giving stock ratings to
Amgen
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

AMGN Stock 12 Month Forecast

Average Price Target

$6,751.03
▼(-10.94% Downside)
Based on 24 Wall Street analysts offering 12 month price targets for Amgen in the last 3 months. The average price target is $6,751.03 with a high forecast of $7,779.60 and a low forecast of $3,889.80. The average price target represents a -10.94% change from the last price of $7,580.50.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"3888":"$3,888","4861":"$4,861","5834":"$5,834","6807":"$6,807","7780":"$7,780"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":7779.6005322,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$8K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6751.032793851818,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$7K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3889.8002661,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$3.89K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[3888,4861,5834,6807,7780],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7580.5,7595.815425553847,7611.130851107692,7626.446276661539,7641.7617022153845,7657.077127769231,7672.392553323077,7687.707978876923,7703.023404430769,7718.338829984616,7733.654255538461,7748.969681092308,7764.2851066461535,{"y":7779.6005322,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7580.5,7516.694830296294,7452.8896605925875,7389.084490888881,7325.279321185175,7261.474151481469,7197.668981777762,7133.863812074055,7070.058642370349,7006.253472666643,6942.448302962936,6878.64313325923,6814.837963555524,{"y":6751.032793851818,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7580.5,7296.600020469231,7012.700040938462,6728.800061407693,6444.900081876924,6161.000102346154,5877.100122815385,5593.2001432846155,5309.300163753846,5025.400184223077,4741.500204692308,4457.600225161539,4173.700245630769,{"y":3889.8002661,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5200.13,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5325.167,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5156.349,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6073.993,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5815.317,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5976.99,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6627.694,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6236.031,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5978.54,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5824.258,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6214.387,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6323.366,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7580.5,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$7,780Average Price Target$6,751Lowest Price Target$3,890
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citi Analyst forecast on MX:AMGN
Geoff Meacham
Citi
Citi
$6,849.43
Hold
-9.64%
Downside
Reiterated
09/09/26
Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (NASDAQ: ASMB), Waters (NYSE: WAT) and Amgen (NASDAQ: AMGN)
Scotiabank Analyst forecast on MX:AMGN
Louise Chen
Scotiabank
Scotiabank
$7,610.48
Buy
0.40%
Upside
Reiterated
09/09/26
Analysts Are Bullish on These Healthcare Stocks: Amgen (AMGN), Tyra Bioscience (TYRA)
HSBC Analyst forecast on MX:AMGN
Morten Herholdt
HSBC
HSBC
$7,525.92→$7,187.67
Hold
-5.18%
Downside
Downgraded
09/09/26
Amgen downgraded to Hold from Buy at HSBCAmgen downgraded to Hold from Buy at HSBC
TD Cowen Analyst forecast on MX:AMGN
Yaron Werber
TD Cowen
TD Cowen
$7,644.3
Buy
0.84%
Upside
Reiterated
09/08/26
TD Cowen Keeps Their Buy Rating on Amgen (AMGN)
Truist Financial Analyst forecast on MX:AMGN
Gregory Renza
Truist Financial
Truist Financial
―
Hold
―
Reiterated
09/08/26
Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN) and NewAmsterdam Pharma Company (NASDAQ: NAMS)
Piper Sandler Analyst forecast on MX:AMGN
David Amsellem
Piper Sandler
Piper Sandler
$7,728.86
Buy
1.96%
Upside
Reiterated
09/08/26
Piper Sandler Reaffirms Their Buy Rating on Amgen (AMGN)
BMO Capital Analyst forecast on MX:AMGN
Evan Seigerman
BMO Capital
BMO Capital
$7,610.48
Hold
0.40%
Upside
Downgraded
09/08/26
Amgen downgraded to Market Perform from Outperform at BMO CapitalAmgen downgraded to Market Perform from Outperform at BMO Capital
Goldman Sachs Analyst forecast on MX:AMGN
Salveen Richter
Goldman Sachs
Goldman Sachs
$7,610.48
Buy
0.40%
Upside
Reiterated
09/08/26
Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN), Guardant Health (NASDAQ: GH) and Neurocrine (NASDAQ: NBIX)
Bank of America Securities Analyst forecast on MX:AMGN
Tazeen Ahmad
Bank of America Securities
Bank of America Securities
$5,361.16
Sell
-29.28%
Downside
Reiterated
09/08/26
Analysts Conflicted on These Healthcare Names: Amgen (NASDAQ: AMGN), Beam Therapeutics (NASDAQ: BEAM) and Royalty Pharma (NASDAQ: RPRX)
William Blair Analyst forecast on MX:AMGN
Matt Phipps
William Blair
William Blair
―
Buy
―
Reiterated
09/08/26
Imdelltra’s Phase III Success in ES-SCLC Underpins Matt Phipps’ Buy Rating on Amgen
Cantor Fitzgerald Analyst forecast on MX:AMGN
Carter Gould
Cantor Fitzgerald
Cantor Fitzgerald
$6,764.87
Hold
-10.76%
Downside
Reiterated
09/05/26
Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN) and Cencora (NYSE: COR)
Wells Fargo Analyst forecast on MX:AMGN
Mohit Bansal
Wells Fargo
Wells Fargo
$7,356.8
Hold
-2.95%
Downside
Assigned
09/04/26
Wells Fargo Reaffirms Their Hold Rating on Amgen (AMGN)
Morgan Stanley Analyst forecast on MX:AMGN
Terence Flynn
Morgan Stanley
Morgan Stanley
$5,936.17→$6,122.21
Hold
-19.24%
Downside
Reiterated
08/19/26
Amgen price target raised to $362 from $351 at Morgan StanleyAmgen price target raised to $362 from $351 at Morgan Stanley
Argus Research Analyst forecast on MX:AMGN
Jasper Hellweg
Argus Research
Argus Research
$7,779.6
Buy
2.63%
Upside
Assigned
08/18/26
Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN) and CVS Health (NYSE: CVS)
Mizuho Securities Analyst forecast on MX:AMGN
Salim Syed
Mizuho Securities
Mizuho Securities
$5,124.39→$5,953.09
Hold
-21.47%
Downside
Reiterated
08/17/26
Analysts Offer Insights on Healthcare Companies: Argenx Se (NASDAQ: ARGX) and Amgen (NASDAQ: AMGN)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citi Analyst forecast on MX:AMGN
Geoff Meacham
Citi
Citi
$6,849.43
Hold
-9.64%
Downside
Reiterated
09/09/26
Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (NASDAQ: ASMB), Waters (NYSE: WAT) and Amgen (NASDAQ: AMGN)
Scotiabank Analyst forecast on MX:AMGN
Louise Chen
Scotiabank
Scotiabank
$7,610.48
Buy
0.40%
Upside
Reiterated
09/09/26
Analysts Are Bullish on These Healthcare Stocks: Amgen (AMGN), Tyra Bioscience (TYRA)
HSBC Analyst forecast on MX:AMGN
Morten Herholdt
HSBC
HSBC
$7,525.92→$7,187.67
Hold
-5.18%
Downside
Downgraded
09/09/26
Amgen downgraded to Hold from Buy at HSBCAmgen downgraded to Hold from Buy at HSBC
TD Cowen Analyst forecast on MX:AMGN
Yaron Werber
TD Cowen
TD Cowen
$7,644.3
Buy
0.84%
Upside
Reiterated
09/08/26
TD Cowen Keeps Their Buy Rating on Amgen (AMGN)
Truist Financial Analyst forecast on MX:AMGN
Gregory Renza
Truist Financial
Truist Financial
―
Hold
―
Reiterated
09/08/26
Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN) and NewAmsterdam Pharma Company (NASDAQ: NAMS)
Piper Sandler Analyst forecast on MX:AMGN
David Amsellem
Piper Sandler
Piper Sandler
$7,728.86
Buy
1.96%
Upside
Reiterated
09/08/26
Piper Sandler Reaffirms Their Buy Rating on Amgen (AMGN)
BMO Capital Analyst forecast on MX:AMGN
Evan Seigerman
BMO Capital
BMO Capital
$7,610.48
Hold
0.40%
Upside
Downgraded
09/08/26
Amgen downgraded to Market Perform from Outperform at BMO CapitalAmgen downgraded to Market Perform from Outperform at BMO Capital
Goldman Sachs Analyst forecast on MX:AMGN
Salveen Richter
Goldman Sachs
Goldman Sachs
$7,610.48
Buy
0.40%
Upside
Reiterated
09/08/26
Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN), Guardant Health (NASDAQ: GH) and Neurocrine (NASDAQ: NBIX)
Bank of America Securities Analyst forecast on MX:AMGN
Tazeen Ahmad
Bank of America Securities
Bank of America Securities
$5,361.16
Sell
-29.28%
Downside
Reiterated
09/08/26
Analysts Conflicted on These Healthcare Names: Amgen (NASDAQ: AMGN), Beam Therapeutics (NASDAQ: BEAM) and Royalty Pharma (NASDAQ: RPRX)
William Blair Analyst forecast on MX:AMGN
Matt Phipps
William Blair
William Blair
―
Buy
―
Reiterated
09/08/26
Imdelltra’s Phase III Success in ES-SCLC Underpins Matt Phipps’ Buy Rating on Amgen
Cantor Fitzgerald Analyst forecast on MX:AMGN
Carter Gould
Cantor Fitzgerald
Cantor Fitzgerald
$6,764.87
Hold
-10.76%
Downside
Reiterated
09/05/26
Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN) and Cencora (NYSE: COR)
Wells Fargo Analyst forecast on MX:AMGN
Mohit Bansal
Wells Fargo
Wells Fargo
$7,356.8
Hold
-2.95%
Downside
Assigned
09/04/26
Wells Fargo Reaffirms Their Hold Rating on Amgen (AMGN)
Morgan Stanley Analyst forecast on MX:AMGN
Terence Flynn
Morgan Stanley
Morgan Stanley
$5,936.17→$6,122.21
Hold
-19.24%
Downside
Reiterated
08/19/26
Amgen price target raised to $362 from $351 at Morgan StanleyAmgen price target raised to $362 from $351 at Morgan Stanley
Argus Research Analyst forecast on MX:AMGN
Jasper Hellweg
Argus Research
Argus Research
$7,779.6
Buy
2.63%
Upside
Assigned
08/18/26
Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN) and CVS Health (NYSE: CVS)
Mizuho Securities Analyst forecast on MX:AMGN
Salim Syed
Mizuho Securities
Mizuho Securities
$5,124.39→$5,953.09
Hold
-21.47%
Downside
Reiterated
08/17/26
Analysts Offer Insights on Healthcare Companies: Argenx Se (NASDAQ: ARGX) and Amgen (NASDAQ: AMGN)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
STOKStoke Therapeutics
AXGNAxoGen
JAZZJazz Pharmaceuticals
PTGXProtagonist Therapeutics
CABACabaletta Bio
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Amgen

3 Months
David AmsellemPiper Sandler
Success Rate
14/19 ratings generated profit
74%
Average Return
+6.94%
Copying David Amsellem's trades and holding each position for 3 Months would result in 73.68% of your transactions generating a profit, with an average return of +6.94% per trade.
1 Year
David AmsellemPiper Sandler
Success Rate
19/19 ratings generated profit
100%
Average Return
+30.33%
Copying David Amsellem's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +30.33% per trade.
2 Years
David AmsellemPiper Sandler
Success Rate
19/19 ratings generated profit
100%
Average Return
+43.11%
Copying David Amsellem's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +43.11% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

AMGN Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
0
0
0
0
0
Buy
25
26
19
24
24
Hold
27
27
22
26
27
Sell
2
2
2
3
4
Strong Sell
0
0
0
0
0
total
54
55
43
53
55
In the current month, AMGN has received 24 Buy Ratings, 27 Hold Ratings, and 4 Sell Ratings. AMGN average Analyst price target in the past 3 months is 6,751.03.
Each month's total comprises the sum of three months' worth of ratings.

AMGN Financial Forecast

AMGN Earnings Forecast

Next quarter’s earnings estimate for AMGN is $98.22 with a range of $93.03 to $104.64. The previous quarter’s EPS was $106.78. AMGN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year AMGN has Performed in-line its overall industry.
Next quarter’s earnings estimate for AMGN is $98.22 with a range of $93.03 to $104.64. The previous quarter’s EPS was $106.78. AMGN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year AMGN has Performed in-line its overall industry.

AMGN Sales Forecast

Next quarter’s sales forecast for AMGN is $170.55B with a range of $167.16B to $174.42B. The previous quarter’s sales results were $170.90B. AMGN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year AMGN has Performed in-line its overall industry.
Next quarter’s sales forecast for AMGN is $170.55B with a range of $167.16B to $174.42B. The previous quarter’s sales results were $170.90B. AMGN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year AMGN has Performed in-line its overall industry.

AMGN Stock Forecast FAQ

What is MX:AMGN’s average 12-month price target, according to analysts?
Based on analyst ratings, Amgen’s 12-month average price target is 6,751.03.
    What is MX:AMGN’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for MX:AMGN, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Amgen a Buy, Sell or Hold?
        Amgen has a consensus rating of Moderate Buy, which is based on 9 buy ratings, 13 hold ratings and 2 sell ratings.
          What is Amgen’s share price target?
          The average share price target for Amgen is 6,751.03. This is based on 24 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $7,779.60 ,and the lowest forecast is $3,889.80. The average share price target represents -10.94% Decrease from the current price of $7,580.5.
            What do analysts say about Amgen?
            Amgen’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 24 Wall Streets Analysts.
              How can I buy shares of Amgen?
              To buy shares of MX:AMGN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.